Abstract
Very rarely therapeutic drug monitoring is evaluated for its ability to provide cost savings. A new article describes the cost-effectiveness of meconium analysis for fatty acid ethyl esters in the management of fetal alcohol spectrum disorder. This article is a summary and a critical appraisal of the article by Hopkins et al.
| Original language | English |
|---|---|
| Pages (from-to) | 170-172 |
| Number of pages | 3 |
| Journal | Therapeutic Drug Monitoring |
| Volume | 31 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2009 |
| Externally published | Yes |
Keywords
- Cost-effectiveness
- Fatty acid ethyl esters
- Fetal alcohol spectrum disorder
- Meconium
- Screening